Pancreatic Cancer

• CLINICAL_TRIALS trial_result · 2021-12-10
  Clinical Trial Update: Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer [Phase 2]

  Phase 2 study of S-1 in locally advanced or metastatic pancreatic cancer has completed with results posted.

• CLINICAL_TRIALS trial_result · 2021-12-03
  Clinical Trial Update: CD276-targeted Chimeric Antigen Receptor T Cells in Treatment With Advanced Pancreatic Cancer [Phase 1, Phase 2]

  Phase 1/2 trial evaluating CD276-targeted CAR-T cells in advanced pancreatic carcinoma.

• CLINICAL_TRIALS trial_result · 2021-11-30
  Clinical Trial Update: A Study of Donafenib Plus S-1 in Treating Patients With Metastatic Pancreatic Cancer After Chemotherapy With Nab-paclitaxel Plus Gemcitabine Regimen [Phase 2]

  Phase 2 clinical trial evaluating donafenib plus S-1 for metastatic pancreatic cancer after nab-paclitaxel plus gemcitabine failure.

• CLINICAL_TRIALS trial_result · 2021-11-30
  Clinical Trial Update: Preoperative Exercise in Pancreatic Cancer [NA]

  Clinical trial completed a preoperative exercise intervention in pancreatic cancer; results posted in 2021.

• CLINICAL_TRIALS trial_result · 2021-10-29
  Clinical Trial Update: A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced Pancreatic Cancer [Phase 2]

  Phase 2 trial of mitoxantrone hydrochloride liposome injection in advanced pancreatic cancer is ongoing with status unknown.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2021-10-22
  Clinical Trial Update: MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease [Phase 2]

  Phase 2 trial update evaluating MFOLFIRINOX plus stereotactic radiotherapy (SBRT) in high-risk and locally advanced pancreatic cancer.

• CLINICAL_TRIALS trial_result · 2021-10-19
  Clinical Trial Update: Study of Nivolumab, Cabiralizumab, and Stereotactic Body Radiotherapy (SBRT) for Locally Advanced Unresectable Pancreatic Cancer [Phase 2]

  Phase 2 trial of nivolumab, cabiralizumab, and SBRT for locally advanced unresectable pancreatic cancer was terminated; results posted in 20…

• CLINICAL_TRIALS trial_result · 2021-10-15
  Clinical Trial Update: Personal Resilience Empowerment Program Study [NA]

  Clinical trial update for a study titled Personal Resilience Empowerment Program; status completed with results posted in 2021.

• CLINICAL_TRIALS trial_result · 2021-10-15
  Clinical Trial Update: Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase)in Patients With Pancreatic Cancer [Phase 1]

  Phase 1 trial update for GRASPA (suspension of erythrocytes encapsulating L-asparaginase) in pancreatic cancer; results posted.

• CLINICAL_TRIALS trial_result · 2021-10-04
  Clinical Trial Update: A Phase 2 Trial of Neoadjuvant Modified FOLFIRINOX Chemotherapy for Resectable Pancreatic Adenocarcinoma [Phase 2]

  Phase 2 trial update of neoadjuvant modified FOLFIRINOX for resectable pancreatic adenocarcinoma.

• CLINICAL_TRIALS trial_result · 2021-09-29
  Clinical Trial Update: A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer [Phase 2]

  Phase 2 trial comparing Gemcitabine with and without IMM-101 in advanced pancreatic cancer has completed with posted results.

• CLINICAL_TRIALS trial_result · 2021-09-27
  Clinical Trial Update: MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery [Phase 2]

  Phase 2 trial update for MDX-010 in stage IV pancreatic cancer unsuitable for surgery; results posted after completion.

• CLINICAL_TRIALS trial_result · 2021-09-21
  Clinical Trial Update: Albumin-bound Paclitaxel Combined With Gemcitabine First-line Inoperable Pancreatic Cancer [Phase 4]

  Phase 4 trial update evaluating albumin-bound paclitaxel plus gemcitabine as first-line therapy for inoperable pancreatic cancer.

• CLINICAL_TRIALS trial_result · 2021-09-20
  Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors [Phase 2]

  Phase 2 trial evaluating TAK-931 in metastatic pancreatic cancer, colorectal cancer, and other advanced solid tumors has completed with post…

• CLINICAL_TRIALS trial_result · 2021-09-09
  Clinical Trial Update: Gemcitabine and Radiation Therapy in Treating Patients With Cancer of the Pancreas [Phase 2]

  A Phase 2 clinical trial evaluating gemcitabine with radiation therapy in pancreatic cancer has completed recruitment.

• CLINICAL_TRIALS trial_result · 2021-09-09
  Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer [Phase 2]

  Phase 2 clinical trial evaluating combination chemotherapy plus radiation therapy for locally advanced unresectable pancreatic cancer.

• CLINICAL_TRIALS trial_result · 2021-09-08
  Clinical Trial Update: BrUOG 295: Adjuvant FOLFOX-A For Resected Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial [Phase 2]

  Phase II trial evaluating adjuvant FOLFOX-A for resected pancreatic cancer has completed with results posted.

• CLINICAL_TRIALS trial_result · 2021-08-19
  Clinical Trial Update: Safety and Efficacy Study of 90Y-hPAM4 at Different Doses [Phase 1, Phase 2]

  Clinical trial update reporting safety and efficacy of 90Y-hPAM4 across Phase 1/Phase 2 in pancreatic cancer.

• CLINICAL_TRIALS trial_result · 2021-08-16
  Clinical Trial Update: Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer [Phase 3]

  Phase 3 trial of 90Y-Clivatuzumab Tetraxetan + Gemcitabine versus placebo + Gemcitabine in metastatic pancreatic cancer was terminated.

• CLINICAL_TRIALS trial_result · 2021-08-16
  Clinical Trial Update: Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic Cancer [Phase 1, Phase 2]

  Clinical trial evaluating safety and efficacy of different doses of 90Y-hPAM4 with gemcitabine in pancreatic cancer has completed phases 1 a…

• CLINICAL_TRIALS trial_result · 2021-08-16
  Clinical Trial Update: Anlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic Cancer [Phase 2]

  Phase 2 clinical trial evaluating anlotinib, toripalimab, and nab-paclitaxel for locally advanced or metastatic pancreatic cancer.

• CLINICAL_TRIALS trial_result · 2021-08-13
  Clinical Trial Update: Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer [Phase 1, Phase 2]

  Phase 1/2 trial evaluating safety and immunological effects of pembrolizumab in resectable or borderline resectable pancreatic cancer.

• CLINICAL_TRIALS trial_result · 2021-08-13
  Clinical Trial Update: BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial [Phase 2]

  Phase II trial update for FOLFOX-A in metastatic pancreatic cancer by BrUOG 292; study completed with results posted.

• CLINICAL_TRIALS trial_result · 2021-08-13
  Clinical Trial Update: FOLFOX-A For Locally Advanced Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial [Phase 2]

  Phase II trial of FOLFOX-A for locally advanced pancreatic cancer has completed with results posted.

• CLINICAL_TRIALS trial_result · 2021-08-10
  Clinical Trial Update: Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer [Phase 2]

  Phase 2 trial assessing metformin plus modified FOLFOX 6 in metastatic pancreatic cancer has completed with results posted.